Cargando…
Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis
Dermatomyositis (DM) is a strikingly heterogenous disease characterized by a broad and ever-evolving spectrum of cutaneous manifestations that transcend the classic “hallmarks” defined by Peter and Bohan in 1975. Despite the increasing preponderance and ubiquity of autoantibody, radiologic, and elec...
Autores principales: | Castillo, Rochelle L., Femia, Alisa N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033358/ https://www.ncbi.nlm.nih.gov/pubmed/33842657 http://dx.doi.org/10.21037/atm-20-5252 |
Ejemplares similares
-
Polishing the crystal ball: mining multi-omics data in dermatomyositis
por: Castillo, Rochelle L., et al.
Publicado: (2021) -
Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?
por: Khanna, Urmi, et al.
Publicado: (2021) -
AB015. Skin disease activity and autoantibody phenotype are major determinants of blood interferon signatures in dermatomyositis
por: Tabata, Mika, et al.
Publicado: (2021) -
AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
por: Concha, Josef Symon S., et al.
Publicado: (2021) -
AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)